Drug
Radio Labeled Osi 906
Radio Labeled Osi 906: highest development phase Phase 1, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| radio-labeled OSI-906 NCT01529684 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Radio Labeled Osi 906 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.